GL1X · GenesisL1 explorer

MolNFT v1 · #104926 · protein

New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption

4QPF · Farnesyl pyrophosphate synthase: “New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal…”. X-ray diffraction, 2 ligands (39L, MG), 2 pockets (best druggability 0.78). MolNFT v1…

PDB
4QPF
Type
protein
Length
337 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Farnesyl pyrophosphate synthase
EC
2.5.1.10, 2.5.1.1
UniProt
P14324
Ligands
39L, MG
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 75% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFarnesyl pyrophosphate synthase (EC 2.5.1.10, 2.5.1.1)protein33775% helix, 1% strandP14324

Ligands and binding sites

  • 39L · [1-fluoro-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid) · ligand · chains A
  • MG · Magnesium ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13980.780.875339L, MG
2610.340.7714empty

Compared structures

  • 4QPF · New lower bone affinity bisphosphonate drug design for effective use in diseases… · the same entry in another collection · chain A against A, TM-score 1.00
  • P14324 · AlphaFold monomer V2.0 prediction for farnesyl pyrophosphate synthase (P14324) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.